A study of the presence of circulating immune complexes in schistosomiasis. 1977

M D Smith, and P J Verroust, and L Morel-Maroger, and M Geniteau, and J P CouLaud

The sera from 51 patients with schistosomiasis were studied for the presence of circulating immune complexes (IC) using two methods, inhibition of EAC rosette formation and precipitation of radio-labelled Clq. The percentage EAC rosette inhibition was significantly greater in the total group of patients compared to the control sera. The material inhibiting EAC rosette formation was precipitable by 4% polyethylene glycol, thus excluding the role of C3 fragments and suggesting that inhibition was due to immune complexes. Using precipitation of radio-labelled Clq significant high values compared to control sera were only obtained in those patients before treatment or with an active infection. The results suggests that material behaving as IC is present in the sera of patients with schistosomiasis and that measurement of the levels of IC may be important in assessing the state of the disease.

UI MeSH Term Description Entries
D008297 Male Males
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations
D012552 Schistosomiasis Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States. Bilharziasis,Katayama Fever,Schistoma Infection,Bilharziases,Fever, Katayama,Infection, Schistoma,Infections, Schistoma,Schistoma Infections,Schistosomiases

Related Publications

M D Smith, and P J Verroust, and L Morel-Maroger, and M Geniteau, and J P CouLaud
July 1977, Immunology,
M D Smith, and P J Verroust, and L Morel-Maroger, and M Geniteau, and J P CouLaud
August 1979, Clinical and experimental immunology,
M D Smith, and P J Verroust, and L Morel-Maroger, and M Geniteau, and J P CouLaud
May 1975, British medical journal,
M D Smith, and P J Verroust, and L Morel-Maroger, and M Geniteau, and J P CouLaud
January 1997, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
M D Smith, and P J Verroust, and L Morel-Maroger, and M Geniteau, and J P CouLaud
November 1980, The Journal of infectious diseases,
M D Smith, and P J Verroust, and L Morel-Maroger, and M Geniteau, and J P CouLaud
September 1989, British journal of urology,
M D Smith, and P J Verroust, and L Morel-Maroger, and M Geniteau, and J P CouLaud
January 1983, The American journal of tropical medicine and hygiene,
M D Smith, and P J Verroust, and L Morel-Maroger, and M Geniteau, and J P CouLaud
March 1979, Clinical and experimental immunology,
M D Smith, and P J Verroust, and L Morel-Maroger, and M Geniteau, and J P CouLaud
November 1983, Bulletin de la Societe de pathologie exotique et de ses filiales,
M D Smith, and P J Verroust, and L Morel-Maroger, and M Geniteau, and J P CouLaud
October 1983, Clinical nephrology,
Copied contents to your clipboard!